Literature DB >> 35536384

Frequency and distribution of TAR DNA-binding protein 43 (TDP-43) pathology increase linearly with age in a large cohort of older adults with and without dementia.

Arenn F Carlos1, Nirubol Tosakulwong2, Stephen D Weigand2, Bradley F Boeve1, David S Knopman1, Ronald C Petersen1, Aivi Nguyen3, R Ross Reichard3, Melissa E Murray4, Dennis W Dickson4, Keith A Josephs5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35536384     DOI： 10.1007/s00401-022-02434-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   15.887


× No keyword cloud information.
  4 in total

1.  Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer's disease: a case-control study.

Authors:  Marina Buciuc; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Bradley F Boeve; David S Knopman; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2020-04-15       Impact factor: 4.673

2.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

3.  Updated TDP-43 in Alzheimer's disease staging scheme.

Authors:  Keith A Josephs; Melissa E Murray; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Leonard Petrucelli; Amanda M Liesinger; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2016-01-25       Impact factor: 17.088

4.  TDP-43 pathology, cognitive decline, and dementia in old age.

Authors:  Robert S Wilson; Lei Yu; John Q Trojanowski; Er-Yun Chen; Patricia A Boyle; David A Bennett; Julie A Schneider
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.